Rapid Micro Biosystems (RPID) Asset Utilization Ratio (2021 - 2026)
Rapid Micro Biosystems (RPID) reported Asset Utilization Ratio of 0.5 for Q1 2026, up 55.2% on a YoY basis from 0.32 in Q1 2025, and up 18.82% sequentially from 0.42 in Q4 2025.
Rapid Micro Biosystems (RPID) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
Rapid Micro Biosystems (RPID) has 6 years of Asset Utilization Ratio data on file, last reported at 0.5 in Q1 2026.
- For the quarter ending Q1 2026, Asset Utilization Ratio rose 55.2% year-over-year to 0.5; the trailing twelve-month figure through Mar 2026 stood at 0.5 (up 55.2% YoY), and the FY2025 full-year result was 0.39, up 67.21% from the prior year.
- Asset Utilization Ratio grew to 0.5 in Q1 2026, from 0.42 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.5 in Q1 2026 to a low of 0.09 in Q3 2022.
- A 5-year average of 0.22 and a median of 0.17 in 2024 frame the typical range for Asset Utilization Ratio.
- Across the five-year window, Asset Utilization Ratio retreated 29.12% in 2022 and jumped 89.59% in 2025, its largest moves.
- Tracing RPID's Asset Utilization Ratio over 5 years: stood at 0.09 in 2022, then jumped by 75.73% to 0.15 in 2023, then jumped by 79.28% to 0.27 in 2024, then soared by 53.38% to 0.42 in 2025, then rose by 18.82% to 0.5 in 2026.
- Business Quant data shows RPID's Asset Utilization Ratio at 0.5 in Q1 2026, 0.42 in Q4 2025, and 0.38 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.47 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.74 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.65 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.57 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Rapid Micro Biosystems | 90.41 Mn | 80.98 Mn | 371,000.00 | 0.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.50 |
| Dec 31, 2025 | 0.42 |
| Sep 30, 2025 | 0.38 |
| Jun 30, 2025 | 0.38 |
| Mar 31, 2025 | 0.32 |
| Dec 31, 2024 | 0.27 |
| Sep 30, 2024 | 0.23 |
| Jun 30, 2024 | 0.20 |
| Mar 31, 2024 | 0.17 |
| Dec 31, 2023 | 0.15 |
| Sep 30, 2023 | 0.13 |
| Jun 30, 2023 | 0.11 |
| Mar 31, 2023 | 0.10 |
| Dec 31, 2022 | 0.09 |
| Sep 30, 2022 | 0.09 |
| Jun 30, 2022 | 0.09 |
| Mar 31, 2022 | 0.10 |
| Dec 31, 2021 | 0.09 |
| Sep 30, 2021 | 0.12 |